March 31, 2010 — A blood test may soon be able to identify which patients with multiple sclerosis will and will not respond to beta interferon. Only a reported two-thirds of patients with ...
Trageting abnormal brain cells linked to chronic inflammation may be key to treating people with progressive forms of MS, a ...
The price of Rebif has increased four times faster than the rate of inflation, with Kay's insurer deciding to stop covering ...
High serum type I interferon (IFN) scores, measured through six chemokines, correlated with poorer lung function and health-related quality of life in patients with diffuse cutaneous systemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback